Immune mechanisms behind prostate cancer in men of African ancestry: A review
Abstract
Men of African ancestry (AA) with prostate cancer suffer from worse outcomes. However, a recent analysis of patients treated with the dendritic cell vaccine sipuleucel‐T for prostate cancer suggested that AA patients could have improved outcomes relative to whites.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Mar 07, 2022
- Source ID
- 10.1002/pros.24333
Entities
People
- Daniel Sentana‐Lledo
- David J Einstein
- Oliver Sartor
- Steven P Balk
Organizations
- Beth Israel Deaconess Medical Center
- Dana Farber Harvard Cancer Center
- Prostate Cancer Foundation
- Tulane University of Louisiana
- United States Department of Defense